{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:11:33Z","timestamp":1792084293430,"version":"4.4.0"},"reference-count":26,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. braz j urol."],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1590\/s1677-55382011000500012","type":"journal-article","created":{"date-parts":[[2011,12,10]],"date-time":"2011-12-10T06:38:37Z","timestamp":1323499117000},"page":"642-648","source":"Crossref","is-referenced-by-count":28,"title":["Botulinum toxin A for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients"],"prefix":"10.1590","volume":"37","author":[{"given":"S.","family":"Deffontaines-Rufin","sequence":"first","affiliation":[{"name":"H\u00f4pital TENON, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Weil","sequence":"additional","affiliation":[{"name":"H\u00f4pital TENON, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Verollet","sequence":"additional","affiliation":[{"name":"H\u00f4pital TENON, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Peyrat","sequence":"additional","affiliation":[{"name":"H\u00f4pital TENON, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Amarenco","sequence":"additional","affiliation":[{"name":"H\u00f4pital TENON, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","first-page":"19","article-title":"The Diagnosis of MS","volume":"16","author":"Mallam E","year":"2009","journal-title":"The International MS Journal"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1097\/01.ju.0000049644.27713.c8","article-title":"Relationship of bladder dysfunction to lesion site in multiple sclerosis","volume":"169","author":"Araki I","year":"2003","journal-title":"J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-5347","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/(SICI)1520-6777(1998)17:2<89::AID-NAU2>3.0.CO;2-8","article-title":"Urological dysfunctions and upper urinary tract involvement in multiple sclerosis patients","volume":"17","author":"Giannantoni A","year":"1998","journal-title":"Neurourol Urodyn","ISSN":"https:\/\/id.crossref.org\/issn\/0733-2467","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society","volume":"21","author":"Abrams P","year":"2002","journal-title":"Neurourol Urodyn","ISSN":"https:\/\/id.crossref.org\/issn\/0733-2467","issn-type":"print"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1212\/WNL.0b013e31818f3da5","article-title":"Identification, causation, alleviation, and prevention of complications (ICAP): an approach to symptom and disability management in multiple sclerosis","volume":"71","author":"Cohen BA","year":"2008","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref6","first-page":"182","article-title":"Overactive bladder: pharmacologic treatments in the neurogenic population","volume":"10","author":"Kennelly MJ","year":"2008","journal-title":"Rev Urol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1177\/1352458506075651","article-title":"GENULF: The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines","volume":"13","author":"de S\u00e8ze M","year":"2007","journal-title":"Mult Scler","ISSN":"https:\/\/id.crossref.org\/issn\/1352-4585","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00019052-200206000-00008","article-title":"Sexual and urological dysfunction in multiple sclerosis: better understanding and improved therapies","volume":"15","author":"DasGupta R","year":"2002","journal-title":"Curr Opin Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/1350-7540","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11934-007-0032-6","article-title":"How to choose the initial drug treatment for overactive bladder","volume":"8","author":"MacDiarmid SA","year":"2007","journal-title":"Curr Urol Rep"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2008.09.009","article-title":"Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report","volume":"55","author":"Apostolidis A","year":"2009","journal-title":"Eur Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0302-2838","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","article-title":"Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study","volume":"174","author":"Schurch B","year":"2005","journal-title":"J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-5347","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.ju.0000132152.53532.5d","article-title":"Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study","volume":"172","author":"Giannantoni A","year":"2004","journal-title":"J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-5347","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1590\/S1677-55382010000100011","article-title":"Experience with different botulinum toxins for the treatment of refractory neurogenic detrusor overactivity","volume":"36","author":"Gomes CM","year":"2010","journal-title":"Int Braz J Urol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","article-title":"Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review","volume":"53","author":"Karsenty G","year":"2008","journal-title":"Eur Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0302-2838","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.urology.2007.06.824","article-title":"Variation between clinical and urodynamical responses in patients receiving intradetrusor botulinum-A for refractory neurogenic detrusor overactivity","volume":"70","author":"Toh KL","year":"2007","journal-title":"Urology","ISSN":"https:\/\/id.crossref.org\/issn\/0090-4295","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.eururo.2007.08.039","article-title":"Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections","volume":"53","author":"Gam\u00e9 X","year":"2008","journal-title":"Eur Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0302-2838","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/nau.20090","article-title":"Botulinum toxin for the treatment of lower urinary tract symptoms: a review","volume":"24","author":"Sahai A","year":"2005","journal-title":"Neurourol Urodyn","ISSN":"https:\/\/id.crossref.org\/issn\/0733-2467","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1464-410X.2008.07820.x","article-title":"Botulinum A toxin in the treatment of neurogenic detrusor overactivity: a consolidated field of application","volume":"102","author":"Giannantoni A","year":"2008","journal-title":"BJU Int"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/nau.20153","article-title":"Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis","volume":"25","author":"Schulte-Baukloh H","year":"2006","journal-title":"Neurourol Urodyn","ISSN":"https:\/\/id.crossref.org\/issn\/0733-2467","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ana.21209","article-title":"Botulinum injections for the treatment of bladder symptoms of multiple sclerosis","volume":"62","author":"Kalsi V","year":"2007","journal-title":"Ann Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0364-5134","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.juro.2010.05.035","article-title":"The effect of botulinum toxin type a on overactive bladder symptoms in patients with multiple sclerosis: a pilot study","volume":"184","author":"Mehnert U","year":"2010","journal-title":"J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-5347","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.47102\/annals-acadmedsg.V36N1p11","article-title":"Botulinum toxin type A for refractory neurogenic detrusor overactivity in spinal cord injured patients in Singapore","volume":"36","author":"Tow AM","year":"2007","journal-title":"Ann Acad Med Singapore","ISSN":"https:\/\/id.crossref.org\/issn\/0304-4602","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch B","year":"2000","journal-title":"J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-5347","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1464-410X.2006.06192.x","article-title":"Botulinum toxin-type A in the treatment of drug-resistant neurogenic detrusor overactivity secondary to traumatic spinal cord injury","volume":"98","author":"Patki PS","year":"2006","journal-title":"BJU Int"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1097\/01.ju.0000180410.78774.b5","article-title":"The effects of botulinum-A toxin on bladder function and histology in spinal cord injured rats: is there any difference between early and late application?","volume":"174","author":"Temeltas G","year":"2005","journal-title":"J Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-5347","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.eururo.2005.12.015","article-title":"Successful treatment with intradetrusor Botulinum-A toxin for urethral urinary leakage (catheter bypassing) in patients with end-staged multiple sclerosis and indwelling suprapubic catheters","volume":"50","author":"Lekka E","year":"2006","journal-title":"Eur Urol","ISSN":"https:\/\/id.crossref.org\/issn\/0302-2838","issn-type":"print"}],"container-title":["International braz j urol"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ibju\/v37n5\/12.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T17:48:57Z","timestamp":1686505737000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1677-55382011000500012&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1677-55382011000500012"],"URL":"https:\/\/doi.org\/10.1590\/s1677-55382011000500012","relation":{},"ISSN":["1677-5538"],"issn-type":[{"value":"1677-5538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}